Stock comparison

INSMvsUTHR

Insmed IncvsUnited Therapeutics Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

INSM

Insmed Inc

$144.48

-26.63%

Biotechnology$35.0BNASDAQ

UTHR

United Therapeutics Corp

$567.16

+13.36%

Biotechnology$23.1BNASDAQ

60-day price, rebased to 100

INSM -8.45% · UTHR +21.27%

Round-by-round

INSM 1·UTHR 5

EdgeUTHR

Valuation upside

-90.50% vs -9.50% to DCF fair value

EdgeUTHR

Balance-sheet strength

Altman Z 9.81 vs 20.69

EdgeUTHR

Fundamental quality

Piotroski 4.00 vs 7.00 (of 9)

EdgeUTHR

Growth + margins

Rule-of-40 -92.80 vs 43.10

EdgeUTHR

60-day momentum

-8.45% vs +21.27% price return

EdgeINSM

Market-cap liquidity

$35.0B vs $23.1B

Verdict

Across6categories,UTHRtakes the edge with5wins to1. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onINSMorUTHR

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.